Denmark · 
Who invested in Antag Therapeutics?
Antag Therapeutics's investors include Versant Ventures, Novo Holdings, SR One, The Danish Growth Fund and Export and Investment Fund.
Denmark · Series A startup
Who invested in Antag Therapeutics
Funding summaryUpdated 26 Oct 2026
$84Mraised across 1 round since 2024, from 1 source
- Latest round
- Series A, $84MDec 2024
- Investors
- 5
The rounds
- Dec 2024Series A$84M
Source recorded
Founders and team
From Antag Therapeutics's own website: 1 founder, 4 on the team.
Everyone who backed them
The Danish Growth FundVC firm1round
Export and Investment FundVC firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Antag Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Antag Therapeutics
How much has Antag Therapeutics raised?
Antag Therapeutics has raised $84M across 1 round since 2024.
When did Antag Therapeutics last raise?
Antag Therapeutics's most recent round was a Series A of $84M in Dec 2024.
What was Antag Therapeutics's biggest round?
Its most recent round, $84M in Dec 2024, is also its largest on record.
Who backed Antag Therapeutics first?
Antag Therapeutics's first round on record, in Dec 2024, was backed by Versant Ventures, Novo Holdings and SR One and 2 others.
What stage is Antag Therapeutics at?
Antag Therapeutics's latest named round is a Series A, in Dec 2024.
Where is Antag Therapeutics based?
Antag Therapeutics is based in Denmark.
Companies like Antag Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.